FR1459501A - Method of removing cytotoxicity from a therapeutic serum - Google Patents

Method of removing cytotoxicity from a therapeutic serum

Info

Publication number
FR1459501A
FR1459501A FR40957A FR40957A FR1459501A FR 1459501 A FR1459501 A FR 1459501A FR 40957 A FR40957 A FR 40957A FR 40957 A FR40957 A FR 40957A FR 1459501 A FR1459501 A FR 1459501A
Authority
FR
France
Prior art keywords
cytotoxicity
therapeutic serum
serum
therapeutic
removing cytotoxicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR40957A
Other languages
French (fr)
Inventor
Michel Plissier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR40957A priority Critical patent/FR1459501A/en
Application granted granted Critical
Publication of FR1459501A publication Critical patent/FR1459501A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
FR40957A 1965-12-03 1965-12-03 Method of removing cytotoxicity from a therapeutic serum Expired FR1459501A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR40957A FR1459501A (en) 1965-12-03 1965-12-03 Method of removing cytotoxicity from a therapeutic serum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR40957A FR1459501A (en) 1965-12-03 1965-12-03 Method of removing cytotoxicity from a therapeutic serum

Publications (1)

Publication Number Publication Date
FR1459501A true FR1459501A (en) 1966-11-18

Family

ID=1581181

Family Applications (1)

Application Number Title Priority Date Filing Date
FR40957A Expired FR1459501A (en) 1965-12-03 1965-12-03 Method of removing cytotoxicity from a therapeutic serum

Country Status (1)

Country Link
FR (1) FR1459501A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010309A2 (en) * 1978-10-25 1980-04-30 BEHRINGWERKE Aktiengesellschaft Agent for treating allergic reactions
AT392003B (en) * 1988-01-13 1991-01-10 Broschek G Chem Prod Gebro METHOD FOR PRODUCING A PARTICULARLY FOR Wounds Healing Or For Treatment In Geriatrics, Active Ingredients From Mammalian Blood By PAPAINE HYDROLYSIS AND A PREPARATION CONTAINING SUCH AN ACTIVE SUBSTANCE

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010309A2 (en) * 1978-10-25 1980-04-30 BEHRINGWERKE Aktiengesellschaft Agent for treating allergic reactions
EP0010309A3 (en) * 1978-10-25 1980-06-25 Behringwerke Aktiengesellschaft Agent for treating allergic reactions and application thereof
AT392003B (en) * 1988-01-13 1991-01-10 Broschek G Chem Prod Gebro METHOD FOR PRODUCING A PARTICULARLY FOR Wounds Healing Or For Treatment In Geriatrics, Active Ingredients From Mammalian Blood By PAPAINE HYDROLYSIS AND A PREPARATION CONTAINING SUCH AN ACTIVE SUBSTANCE

Similar Documents

Publication Publication Date Title
FR1513458A (en) Process for the separation of conjugated diolefins
FR1502673A (en) Process for the preparation of aminoalkanenitriles
FR1439192A (en) Process for the preparation of nu-substituted alpha-pyrrolidones
CH475018A (en) Process for the separation of a dissolved water-soluble substance
CH466631A (en) Turf treatment process
FR1459501A (en) Method of removing cytotoxicity from a therapeutic serum
CH476006A (en) Process for the preparation of amino-oxadiazoles
CH459166A (en) Process for the simultaneous production of a styrene and an epoxy
FR1500508A (en) Process for the preparation of acetylenic amines
FR1483901A (en) Method of removing pyrogenicity from a therapeutic serum
FR1531852A (en) Method of masking the surface of a support
CH457721A (en) Tetracycline extraction and purification process
FR1462916A (en) Process for the preparation of glycol hemi-ethers
CH477553A (en) Process for the preparation of a live rubella virus
FR1506790A (en) Process for the preparation of elastomers
FR1496885A (en) Process for the preparation of a diurethane epoxide
FR1436746A (en) Polonium extraction process
FR1426594A (en) Process for the preparation of a polyurethane
FR1503158A (en) Process for the preparation of alpha-aminocarboxylic acids
FR1473910A (en) Process for the preparation of a novel 3-methoxyoestradiol ester
FR1465336A (en) Process for the selective hydrogenation of a cycloalkadiene
FR1473374A (en) Process for the reduction of halosilicon combinations
CH498107A (en) Process for the preparation of a 3-beta-diethylaminoethoxy-20-keto-delta-5-6-pregnane
CH526003A (en) Method of launching a crossing structure
FR1465918A (en) Process for the preparation of a concentrate of a bifidigene factor